Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × sapanisertib × Clear all

Phase

Status

Completed 23 Terminated 5 Withdrawn 4 Active not recruiting 4 Recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

Cisplatin 450 Radiotherapy 330 Cyclophosphamide 315 Carboplatin 302 Paclitaxel 289 Capecitabine 289 Oxaliplatin 279 Docetaxel 273 Gemcitabine 267 Fluorouracil 245 apatinib 222 Drug Therapy 220 Bevacizumab 202 camrelizumab 183 Etoposide 173 Irinotecan 157 Doxorubicin 154 Leucovorin 133 Dexamethasone 131 Cytarabine 127 Blood Specimen Collection 126 pembrolizumab 122 Neoadjuvant Therapy 119 sintilimab 116 Pemetrexed 115 anlotinib 113 Surgical Procedures, Operative 109 Rituximab 109 toripalimab 108 S 1 (combination) 107

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03745911 2018-11-19

Paclitaxel and TAK-228 in Urothelial Carcinoma

Associació per a la Recerca Oncologica, Spain

Phase 2 Unknown

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡